Praveen Kumar, Director and Heard of Clinical Sciences at nference, a physician, clinical pharmacologist and an advocate for real-world data in drug development and medical devices. Praveen is passionate about leveraging AI, machine learning and data-driven insights to optimize clinical trials, reduce development costs and improve patient outcomes

In this episode, we explore the critical role of real-world data in shaping the future of medicine, how it differs from traditional clinical trials and why it’s increasingly being used for regulatory approvals. Praveen shares real-world case studies of drugs and devices that have successfully used real-world data, the challenges in global regulatory acceptance and how AI is transforming patient recruitment and trial efficiency

Timestamps:

[00:00:27] What is Real-World Data?

[00:02:30] The Key Differences Between Clinical Trials and Real-World Data

[00:06:46] How Real-World Data is Used for Drug Approvals

[00:08:28] Cutting Drug Development Costs with AI

[00:15:33] The Growing Role of Drug-Device Combinations

[00:21:53] Emerging Trends in AI and Real-World Evidence

[00:25:38] Challenges in Global Regulatory Acceptance

Get in touch with Praveen Kumar - https://www.linkedin.com/in/praveen-kumar-m-33a6bab3/

https://nference.com/

Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/

Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal

Subscribe to the Podcast